Literature DB >> 14718250

The contractile action of leukotriene B4 in the guinea-pig lung involves a vascular component.

Kiyoto Sakata1, Sven-Erik Dahlén, Magnus Bäck.   

Abstract

Leukotriene B4 (LTB4) is a potent leukocyte chemoattractant, acting on specific receptors, BLT receptors. The aim of this study was to examine the mechanism of action of LTB4 in the guinea-pig lung, using strips of lung parenchyma (GPLP), spirals of trachea (GPT) and bronchus (GPB) and rings of pulmonary artery (GPPA). Mechanical responses were studied in organ baths, and mediator release was assessed using enzyme immuno assay. LTB4 induced similar contractions of GPLP and GPPA, whereas LTB4 had only small contractile effects in GPT and GPB. In addition, the contractile response to LTB4 was reproduced in the human pulmonary artery. In the GPLP, the unselective BLT receptor antagonist ONO-4057 abolished the contractions induced by LTB4, whereas the selective BLT1 receptor antagonist U-75302 only partly inhibited the LTB4-induced contractions. In the GPPA, both antagonists abolished the response to LTB4. The effect of LTB4 in GPPA and GPLP was indirect and mediated by the release of thromboxane A2 and histamine, as supported by selective pharmacologic interventions and measurements of thromboxane B2 and histamine in the organ baths. In conclusion, the results indicate a new biological function of LTB4, namely to constrict isolated pulmonary arteries. Moreover, the findings suggest that the LTB4-induced contractions of GPPA were mediated by a BLT1 receptor, whereas BLT2 receptor activation accounted for a major part of the contraction of GPLP, making the latter preparation a suitable assay for BLT2 receptors. British Journal of Pharmacology (2004) 141, 449-456. doi:10.1038/sj.bjp.0705641

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718250      PMCID: PMC1574222          DOI: 10.1038/sj.bjp.0705641

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment.

Authors:  Andrew M Tager; Shannon K Bromley; Benjamin D Medoff; Sabina A Islam; Scott D Bercury; Erik B Friedrich; Andrew D Carafone; Robert E Gerszten; Andrew D Luster
Journal:  Nat Immunol       Date:  2003-08-31       Impact factor: 25.606

2.  Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4.

Authors:  Vanessa L Ott; John C Cambier; John Kappler; Philippa Marrack; Bradley J Swanson
Journal:  Nat Immunol       Date:  2003-08-31       Impact factor: 25.606

3.  Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues.

Authors:  Katayoon Goodarzi; Mahmoud Goodarzi; Andrew M Tager; Andrew D Luster; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2003-08-31       Impact factor: 25.606

4.  The cat lung strip as an in vitro preparation of peripheral airways: a comparison of beta-adrenoceptor agonists, autacoids and anaphylactic challenge on the lung strip and trachea.

Authors:  K M Lulich; H W Mitchell; M P Sparrow
Journal:  Br J Pharmacol       Date:  1976-09       Impact factor: 8.739

Review 5.  International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.

Authors:  Charles Brink; Sven-Erik Dahlén; Jeffrey Drazen; Jilly F Evans; Douglas W P Hay; Simonetta Nicosia; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

6.  Threonine 308 within a putative casein kinase 2 site of the cytoplasmic tail of leukotriene B(4) receptor (BLT1) is crucial for ligand-induced, G-protein-coupled receptor-specific kinase 6-mediated desensitization.

Authors:  Remi Gaudreau; Christian Le Gouill; Marie-Hélène Venne; Jana Stankova; Marek Rola-Pleszczynski
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

Review 7.  Functional characteristics of cysteinyl-leukotriene receptor subtypes.

Authors:  Magnus Bäck
Journal:  Life Sci       Date:  2002-06-28       Impact factor: 5.037

8.  A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.

Authors:  T Yokomizo; K Kato; K Terawaki; T Izumi; T Shimizu
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

9.  Molecular and biological characterization of the murine leukotriene B4 receptor expressed on eosinophils.

Authors:  W W Huang; E A Garcia-Zepeda; A Sauty; H C Oettgen; M E Rothenberg; A D Luster
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

10.  "Contractile interstitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluorescence, and in vitro studies.

Authors:  Y Kapanci; A Assimacopoulos; C Irle; A Zwahlen; G Gabbiani
Journal:  J Cell Biol       Date:  1974-02       Impact factor: 10.539

View more
  5 in total

Review 1.  BLT1: a promising therapeutic approach for atherosclerosis.

Authors:  P Zeng; J Yang
Journal:  Herz       Date:  2015-12-10       Impact factor: 1.443

2.  Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.

Authors:  Magnus Bäck; De-xiu Bu; Robert Bränström; Yuri Sheikine; Zhong-Qun Yan; Göran K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

Review 3.  Inflammatory signaling through leukotriene receptors in atherosclerosis.

Authors:  Magnus Bäck
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

Review 4.  Leukotrienes as modifiers of preclinical atherosclerosis?

Authors:  Graziano Riccioni; Magnus Bäck
Journal:  ScientificWorldJournal       Date:  2012-05-01

5.  The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice.

Authors:  Adriana M C Canavaci; Carlos A Sorgi; Vicente P Martins; Fabiana R Morais; Érika V G de Sousa; Bruno C Trindade; Fernando Q Cunha; Marcos A Rossi; David M Aronoff; Lúcia H Faccioli; Auro Nomizo
Journal:  Mediators Inflamm       Date:  2014-08-03       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.